IMPROVED SURVIVAL TIMES IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU - M-2 PROTOCOL

被引：239

作者：

CASE, DC

LEE, BJ

CLARKSON, BD

机构：

[1] MEM SLOAN KETTERING CANC CTR, DEPT MED, NEW YORK, NY 10021 USA

[2] MAINE MED CTR, PORTLAND, ME 04102 USA

来源：

关键词：

D O I：

10.1016/0002-9343(77)90543-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：897 / 903

页数：7

共 37 条

[1] ALBERTS DS, 1976, LANCET, V1, P926
[2] ALBERTS DS, 1975, CANCER CHEMOTH REP 1, V59, P345
[3] ALBERTS DS, 1974, CANCER RES, V34, P2911
[4] ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO
[5] 2-I
[6] ALEXANIAN R, 1972, CANCER-AM CANCER SOC, V30, P382, DOI 10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO
[7] 2-C
[8] TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS
ALEXANIAN, R
HAUT, A
KHAN, AU
LANE, M
MCKELVEY, EM
MIGLIORE, PJ
STUCKEY, WJ
WILSON, HE
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) : 1680 - +
[9] TREATMENT OF PLASMA-CELL MYELOMA WITH CYTOTOXIC AGENTS
BERGSAGEL, DE
PRUZANSKI, W
[J]. ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (01) : 172 - 176
[10] BERSAGEL DE, 1972, J CAN MED ASSOC, V107, P851